Blog

How to Improve Trials: Biomarker Access, Trop-2 & MDD/Diabetes

A focused analysis of trial improvement: standardizing breast cancer biomarkers for access, commercial drivers for Trop-2 therapies, and retention strategies for MDD and diabetes with seasonal decentralized enrollment tactics.

Future Trials: BCI Rehab, Safe Depression Studies & Alzheimer's Guide

Stories of Ana, Marta and Laila show how trials — from BCI rehab for stroke survivors to safe depression studies and Alzheimer's research — become practical paths forward. Learn how to join safely, compare approaches, and protect brain health during flu and cancer seasons.

Trial Trends 2025: BCI, Cancer Depression & Cognitive Protection

An authoritative deep dive into 2025 neurotrial trends: brain-computer interfaces for movement, trial options for depression during cancer care, and research-backed cognitive protection tips for flu season.

Actionable Global IND & ICH E6(R3): Emerging-Market Site Tips

Site-level playbook for ICH E6(R3) and Global IND strategy for oncology trials: step-by-step actions, inspection readiness tips, and questions patients should ask their doctors.

Case Study: Multilingual eConsent, Clinics & Rural Women in Neurotech

A case study showing how multilingual eConsent, clinic partnerships, and season-aware timelines boost inclusive neurotechnology recruitment for women and rural patients.

How to Navigate Expedited Oncology INDs, Trop-2, IRB & BCI SaMD

Regulatory momentum is accelerating for expedited oncology INDs, Trop‑2 combinations and BCI SaMD. This analysis outlines FDA/EMA signals, safety and IRB harmonization trends, and actionable steps for sponsors and patients.

Expert Playbook: BCI Consent, Flu Scheduling & Inclusive Trial Care

Analytical playbook for consent, scheduling, and inclusive pathways: lessons from 2024–2025 data on BCI consent, flu-season visits, Trop2 breast cancer trials, and supporting pregnant/postpartum participants.

The Future of Trial Engagement: Navigation, Telehealth, Remote Tracking

{ "content": "The future of trial engagement is rapidly shifting from site-centric workflows to patient-centered, technology-enabled journeys. Sponsors and pharmaceutical project managers are reconciling operational realities with participant expectations: easier discovery, lower burden, and me...